Oral semaglutide, known by the brand name Wegovy, has been studied for its effectiveness in weight loss. Some reports indicate that it delivers significant weight loss, while others suggest that a similar medication, orforglipron, may be more effective in certain trials. The FDA has approved oral Wegovy following positive trial results, but the comparative effectiveness of oral semaglutide and orforglipron is not entirely clear.